102 related articles for article (PubMed ID: 118304)
1. Therapeutic trial of a combination of broxyquinoline and brobenzoxaldine in the treatment of leprosy.
Hazra SK; Ghosh S; Kundu SK; Chaudhuri S
Lepr India; 1979 Oct; 51(4):505-10. PubMed ID: 118304
[No Abstract] [Full Text] [Related]
2. Letter: Effect of broxyquinoline and broxaldine in leprosy.
Sharma CS
Lancet; 1975 Feb; 1(7903):405. PubMed ID: 46561
[No Abstract] [Full Text] [Related]
3. Comparative study of the efficacy of chloramphenicol and a combination of chloramphenicol, broxyquinoline and brobanzoxaldine in the treatment of enteric fever.
Edibam BM
Indian Pediatr; 1975 Jul; 12(7):587-91. PubMed ID: 810421
[No Abstract] [Full Text] [Related]
4. A study on the neurotoxicity of broxyquinoline and brobenzoxaldine combination in therapeutic doses.
Swain R; Bapna JS; Das AK; Chandrasekar S; Swaminathan RP; Bosco B; Veliath S; Thombre DP
Hum Toxicol; 1986 Jan; 5(1):35-41. PubMed ID: 3081428
[TBL] [Abstract][Full Text] [Related]
5. Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination.
Swain R; Bapna JS
Hum Toxicol; 1986 Jan; 5(1):63-4. PubMed ID: 3081430
[TBL] [Abstract][Full Text] [Related]
6. Results obtained in Intestopan treatment of patients with dysenteric syndrome (adult patients).
Münnich D; Bakondi M
Ther Hung; 1975; 23(2):77-80. PubMed ID: 810910
[No Abstract] [Full Text] [Related]
7. [Sensitivity of E. coli to intestopan].
Sedova NN
Lab Delo; 1980; (8):493-4. PubMed ID: 6157907
[No Abstract] [Full Text] [Related]
8. [Use of enteroseptal and its analogs].
Smirnov AN
Feldsher Akush; 1977 Sep; 42(9):39-40. PubMed ID: 145967
[No Abstract] [Full Text] [Related]
9. [Toxicity of hydroxyquinoline derivatives].
Pashov D; Simeonov SP; Drumev D; Peĭnikova Ts; Dzhurov A
Vet Med Nauki; 1980; 17(3):118-23. PubMed ID: 6784325
[TBL] [Abstract][Full Text] [Related]
10. [Study of a drug combination with contraceptive, antibacterial, antimycotic and prophylactic action, for topical use in venereal diseases. 4. Effect of the combination of oxyquinoline sulfate, copper sulfate and lactic acid on Trichomonas vaginalis and on Candida albicans in vivo].
Gallo G; Marcellino LR; Santoro S; Orzi C; Cellini C
Clin Ter; 1980 Jul; 94(1):39-55. PubMed ID: 6777111
[No Abstract] [Full Text] [Related]
11. Fungus superinfection in chronic obstructive airway disease.
Chaubey BS; Mehra KB; Grover S
Indian J Chest Dis; 1975 Jan; 17(1):8-14. PubMed ID: 812811
[No Abstract] [Full Text] [Related]
12. Therapeutic evaluation of various drugs in giardiasis (a comparative trial).
Khosla SN; Khosla P
Mod Med Asia; 1978 Oct; 14(10):31-4. PubMed ID: 101765
[No Abstract] [Full Text] [Related]
13. [8-Hydroxyquinoline derivatives in the treatment of patients with onychomycoses].
Butareva TA; Kukushkin AM; Unzhakov VP; Nemkaeva RM
Vestn Dermatol Venerol; 1986; (12):50-3. PubMed ID: 2951932
[No Abstract] [Full Text] [Related]
14. [Remote results of treatment of patients with contagious forms of syphilis according to schedules of continuous treatment].
Frishman MP; Nakonechnaia ZS; Dunaeva GA; Nikol'skaia EP; Tatskaia LS
Vestn Dermatol Venerol; 1976 May; (5):45-8. PubMed ID: 823733
[No Abstract] [Full Text] [Related]
15. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
Languillon J; Yawalkar SJ; McDougall AC
Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
[No Abstract] [Full Text] [Related]
16. [Therapeutic experience with 5-chloro-8-hydroxyquinoline].
Gärtner R; Kaben U
Dermatol Monatsschr; 1977 Sep; 163(9):711-4. PubMed ID: 411692
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of skin tissue losses of different etiologies with 8-oxyquinoline associated with local anesthetics].
Passarino M; Bogetti P; Lo Presti F; Perla A; Casale A; Giachero E; Anfossi G
Minerva Chir; 1983 Jul 15-31; 38(13-14):1113-9. PubMed ID: 6415546
[No Abstract] [Full Text] [Related]
18. [Indices for the user of halogenized 8-hydroxyquinolines in dermatology].
Levkov AA; Dubiaga AN
Vestn Dermatol Venerol; 1977 Feb; (2):69-72. PubMed ID: 404774
[No Abstract] [Full Text] [Related]
19. [Use of quinosol and salicylic acid in demexide for treatment of onychomycosis].
Baranov AF; Arievich AM
Vestn Dermatol Venerol; 1979 Oct; (10):69-71. PubMed ID: 159578
[No Abstract] [Full Text] [Related]
20. [Use of hydroxyquinoline sulfate in ophthalmology. 1. Preliminary studies on the formation of eye drops].
Horsch W; Finke I; Weller K; Lippold E
Pharmazie; 1983 Apr; 38(4):262-5. PubMed ID: 6408653
[No Abstract] [Full Text] [Related]
[Next] [New Search]
